Primary regulatory
Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study (PEARL).
ClinicalTrials.gov. Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study (PEARL). NCT04488601. Sponsor: AgelessRx. Last update posted 2024-01-24.
ClinicalTrials.govPublished 2024-01-24Accessed 2026-07-12
Registry record
Source metadata
- Publisher
- ClinicalTrials.gov
- Source type
- Primary regulatory
- Registry ID
research-rapa-04- Trial ID
- NCT04488601
- Source code
- RAPA-04
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.